|
BIA donates for treatment of boy with spinal muscular atrophy
Kris, a 19-month-old boy from Slovenia, was born with spinal muscular atrophy—a rare and devastating genetic disorder that had been incurable until this year's revolutionary launch of gene therapy treatment called Zolgensma. The drug now successfully saves lives of children who would otherwise die before reaching the age of two. BIA's team is proud to announce that treatment with Zolgensma drug was developed with the help of our unique technology, which is used for the purpose of drug purification.
It is a true honor to support the treatment that will save a child's life not only in terms of our scientific contribution but also by a generous financial donation. Sufficient funds, raised in a national-level charity, will help Kris obtain the required treatment.
|
